Treace Medical Concepts (TMCI) Competitors $7.98 +0.22 (+2.84%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TMCI vs. SIBN, ORGO, KIDS, ANGO, SGHT, TNDM, RXST, NVCR, INMD, and MDXGShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include SI-BONE (SIBN), Organogenesis (ORGO), OrthoPediatrics (KIDS), AngioDynamics (ANGO), Sight Sciences (SGHT), Tandem Diabetes Care (TNDM), RxSight (RXST), NovoCure (NVCR), InMode (INMD), and MiMedx Group (MDXG). These companies are all part of the "medical" sector. Treace Medical Concepts vs. SI-BONE Organogenesis OrthoPediatrics AngioDynamics Sight Sciences Tandem Diabetes Care RxSight NovoCure InMode MiMedx Group SI-BONE (NASDAQ:SIBN) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation. Is SIBN or TMCI more profitable? SI-BONE has a net margin of -23.82% compared to Treace Medical Concepts' net margin of -30.33%. SI-BONE's return on equity of -22.51% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets SI-BONE-23.82% -22.51% -16.53% Treace Medical Concepts -30.33%-51.12%-26.36% Which has higher valuation and earnings, SIBN or TMCI? SI-BONE has higher earnings, but lower revenue than Treace Medical Concepts. SI-BONE is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSI-BONE$138.89M3.67-$43.34M-$0.92-13.21Treace Medical Concepts$187.12M2.66-$49.53M-$0.99-8.06 Which has more risk & volatility, SIBN or TMCI? SI-BONE has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500. Do analysts prefer SIBN or TMCI? SI-BONE currently has a consensus price target of $23.00, suggesting a potential upside of 89.30%. Treace Medical Concepts has a consensus price target of $7.40, suggesting a potential downside of 7.27%. Given SI-BONE's stronger consensus rating and higher possible upside, equities research analysts plainly believe SI-BONE is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SI-BONE 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Treace Medical Concepts 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of SIBN or TMCI? 98.1% of SI-BONE shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 3.9% of SI-BONE shares are held by insiders. Comparatively, 24.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to SIBN or TMCI? In the previous week, SI-BONE had 16 more articles in the media than Treace Medical Concepts. MarketBeat recorded 17 mentions for SI-BONE and 1 mentions for Treace Medical Concepts. SI-BONE's average media sentiment score of 0.77 beat Treace Medical Concepts' score of 0.25 indicating that SI-BONE is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SI-BONE 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer SIBN or TMCI? SI-BONE received 144 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 68.29% of users gave SI-BONE an outperform vote while only 47.06% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformSI-BONEOutperform Votes16868.29% Underperform Votes7831.71% Treace Medical ConceptsOutperform Votes2447.06% Underperform Votes2752.94% SummarySI-BONE beats Treace Medical Concepts on 15 of the 18 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$483.42M$4.47B$5.07B$8.89BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-8.0612.2983.5712.93Price / Sales2.6644.861,220.3088.33Price / CashN/A52.2739.4636.25Price / Book4.755.766.936.25Net Income-$49.53M$13.76M$119.12M$225.93M7 Day Performance4.59%-1.08%-1.83%-1.32%1 Month Performance48.88%0.58%-3.64%0.60%1 Year Performance-6.12%50.91%31.64%26.23% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts1.0224 of 5 stars$7.98+2.8%$7.40-7.3%-7.1%$483.42M$187.12M-8.06250SIBNSI-BONE4.3736 of 5 stars$12.15-1.4%$23.00+89.3%-32.6%$516.68M$138.89M0.00350Analyst ForecastInsider TradeAnalyst RevisionORGOOrganogenesis4.1049 of 5 stars$3.97-2.7%$5.33+34.3%+51.5%$540.91M$433.14M-66.17950Analyst RevisionKIDSOrthoPediatrics4.0997 of 5 stars$25.50+4.9%$40.00+56.9%-19.9%$588.93M$148.73M-20.73200ANGOAngioDynamics4.7568 of 5 stars$6.74+0.3%$12.00+78.0%-1.9%$273.06M$303.91M-1.11748Positive NewsSGHTSight Sciences2.5151 of 5 stars$3.73-1.1%$5.50+47.5%+63.6%$191.35M$81.06M0.00210TNDMTandem Diabetes Care4.7486 of 5 stars$30.15+8.2%$54.25+79.9%+63.7%$1.83B$747.72M-15.622,400Positive NewsRXSTRxSight3.0052 of 5 stars$44.81-0.7%$61.63+37.5%+58.7%$1.82B$89.08M0.00220Insider TradeNVCRNovoCure3.7354 of 5 stars$16.86+2.3%$26.17+55.2%+38.3%$1.78B$509.34M-12.041,453INMDInMode2.3243 of 5 stars$18.24+3.0%$22.60+23.9%-19.3%$1.49B$492.05M9.86480MDXGMiMedx Group3.1237 of 5 stars$9.06-1.9%$12.00+32.5%+26.4%$1.36B$321.48M16.47895 Related Companies and Tools Related Companies SI-BONE Alternatives Organogenesis Alternatives OrthoPediatrics Alternatives AngioDynamics Alternatives Sight Sciences Alternatives Tandem Diabetes Care Alternatives RxSight Alternatives NovoCure Alternatives InMode Alternatives MiMedx Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TMCI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
